September 11, 2018 | Dory Benford
Johnny Lopez's research into the latest prostate cancer treatments, clinical trials, experimental therapies — anything to avoid chemotherapy, and a recommendation from a friend also battling prostate cancer, led him to Tanya Dorff, M.D., and City of Hope.
CAR T researcher Saul Priceman wants to teach your body to fight cancer
September 13, 2018 | Letisia Marquez
Since 2013, City of Hope researcher Saul Priceman, Ph.D., and his team have developed one of most comprehensive CAR T programs in the nation.
New Briskin Center for Clinical Research opens at City of Hope
September 7, 2018 | Michael Easterling
By moving all of the clinical research services and staff to one place, we are enabling many of our patients to complete all of their clinical trial appointments in a single visit at a single location. The Briskin Center includes infusion areas, nursing stations, exam and procedure rooms, onsite pharmacy and lab services, a dedicated registration site and outdoor seating for patients and their families.
Lucy’s Story: Immunotherapy Trial Gives Lymphoma Patient New Hope
July 19, 2018 | Dory Benford
After many complications, City of Hope lymphoma patient Lucy found renewed hope after an immunotherapy clinical trial.
City of Hope Awarded $3.7 million to Develop Glioblastoma Clinical Trial
June 29, 2018 | Letisia Marquez
California Institute for Regenerative Medicine has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients, which would genetically alter blood stem cells to better tolerate chemotherapy.
Researchers Discover Breakthrough Treatment For Advanced Squamous Cell Carcinoma
June 7, 2018 | Maxine Nunes
A couple of years ago, Timothy Satterfield, a retired chef, noticed a tiny mole on his forehead. He was referred to City of Hope, where a breakthrough immunotherapy trial is proving to be a game changer.
First FDA-approved CAR T Therapy for Some Types of ALL to Be Offered at City of Hope
April 13, 2018 | Letisia Marquez
City of Hope recently announced that it is a certified treatment center to administer tisagenlecleucel CAR T cell therapy – the first CAR T cell therapy approved by the U.S. Food and Drug Administration – to patients.
Facing Down Uncertainty: Meet Benjamin Djulbegovic, M.D., Ph.D.
March 1, 2018 | Wayne Lewis
The unknown can be scary. But according to City of Hope hematologist Benjamin Djulbegovic, M.D., Ph.D., it’s important to face uncertainty — at least enough to understand it.
Advanced Lung Cancer Patient: ‘I’m Not About to Go Quietly into the Night’
November 30, 2017 | Julia F.
Julie F., 59, of Wisconsin, survived advanced small cell lung cancer after 29 rounds of chemotherapy, five weeks of radiation and experimental immunotherapy. This is her story.